Tolerance and Efficacy of Rituximab in Sjogren's Disease

Clinical trial NCT00740948 · COMPLETED

Trial details

NCT number: NCT00740948
Sponsor: University Hospital, Brest
Status: COMPLETED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Sjogren's Disease

Start date: 2008-03-01
Primary completion: 2012-01-01
Enrollment: 122

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.